APOBEC3C is a novel target for the immune treatment of lower-grade gliomas-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

APOBEC3C is a novel target for the immune treatment of lower-grade gliomas

Published:2023-11-26 Issue:3 Volume:46 Page:227-242
ISSN:0161-6412
Container-title:Neurological Research
language:en
Short-container-title:Neurological Research

Author:

Zhao Shufa¹,Li Yuntao¹,Xu Jie¹,Shen Liang²^ORCID

Affiliation:

1. Department of Neurosurgery, Huzhou Cent Hospital, Affiliated Cent Hospital Huzhou University, Huzhou, Zhejiang, China

2. Department of Neurosurgery, The affiliated Changzhou Second People’s Hospital of Nanjing Medical University, Changzhou, Jiangsu, China

Funder

Young Talent Development Plan of Changzhou Health Commission

Major Scientific Project of Changzhou

Publisher

Informa UK Limited

Subject

Neurology (clinical),Neurology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/01616412.2023.2287340

Reference62 articles.

1. A Prognostic Signature for Lower Grade Gliomas Based on Expression of Long Non-Coding RNAs

Coronin 3 Promotes the Development of Oncogenic Properties in Glioma Through the Wnt/β-Catenin Signaling Pathway

3. Tumor-treating fields induce autophagy by blocking the Akt2/miR29b axis in glioblastoma cells

4. The Rational Development of CD133-Targeting Immunotherapies for Glioblastoma

5. Phase 1b/2a study of galunisertib, a small molecule inhibitor of transforming growth factor-beta receptor I, in combination with standard temozolomide-based radiochemotherapy in patients with newly diagnosed malignant glioma

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP